COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Mimix Biotherapeutics uses Sound Induced Morphogenesis to pattern cells, spheroids, and bioactives for tissue-relevant biofabrication, developing FastSkin dermal substitutes for acute and chronic wounds and pursuing FDA approval.
Focus Areas
Recent Investors
Funding round
Investors
